Bilayer Therapeutics

Bilayer Therapeutics

  • Founded: 2020
  • Location: Cambridge, MA
  • Employee range: 1 - 10
  • Clinical stage: Clin0
  • Therapy area: Chronic idiopathic constipation
  • Drug types: GI
  • Lead product: BL-010
  • Product link:

Short description:

Bile acid delivered via proprietary bilayer tablet technology

Drug notes:

also Clin0 constipation-dominant IBD, hepatic encephalopathy; BL-020 Clin0 opioid-induced constipation; BL-030 RD UC; BL-040 RD Crohn's; BL-050 RD metabolic disorders

Long description:

ilayer Therapeutics, a development-stage biotech company, provides a novel approach to developing treatments for gastrointestinal disease and metabolic disorder. They were founded in 2020 by drug development and delivery experts and gastroenterologists. They hope to target the body’s innate mechanism to restore normal metabolism and motility.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy